236 related articles for article (PubMed ID: 7111310)
21. The inhibition of cancer cell stickiness: a model for investigation of platelet aggregation inhibitors in vivo. V. The effect of penbutolol.
Gastpar H; Weissgerber PW
J Med; 1981; 12(1):1-13. PubMed ID: 6943263
[No Abstract] [Full Text] [Related]
22. Inhibition of tumor cell induced platelet aggregation by prostacyclin and carbacyclin: an ultrastructural study.
Menter DG; Harkins C; Onoda J; Riorden W; Sloane BF; Taylor JD; Honn KV
Invasion Metastasis; 1987; 7(2):109-28. PubMed ID: 3294727
[TBL] [Abstract][Full Text] [Related]
23. Quantification and morphologic demonstration of reactive oxygen species produced by Walker 256 tumor cells in vitro and during metastasis in vivo.
Soares FA; Shaughnessy SG; MacLarkey WR; Orr FW
Lab Invest; 1994 Oct; 71(4):480-9. PubMed ID: 7967504
[TBL] [Abstract][Full Text] [Related]
24. Possible strategies for antimetastastic therapy.
Honn KV; Onoda JM; Menter DG; Cavanaugh PG; Taylor JD; Crissman JD; Ryan RE; Sloane BF
Prog Clin Biol Res; 1986; 212():217-49. PubMed ID: 3520578
[No Abstract] [Full Text] [Related]
25. The inhibition of cancer cell stickness by the methylxanthine derivative pentoxifylline (BL 191).
Gastpar H
Thromb Res; 1974 Sep; 5(3):277-89. PubMed ID: 4373868
[No Abstract] [Full Text] [Related]
26. Inhibition of platelet function: does it offer a chance of better cancer progression control?
Sierko E; Wojtukiewicz MZ
Semin Thromb Hemost; 2007 Oct; 33(7):712-21. PubMed ID: 18000800
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of cancer cell stickiness by the blocking of platelet aggregation.
Gastpar H
S Afr Med J; 1974 Mar; 48(15):621-7. PubMed ID: 4823720
[No Abstract] [Full Text] [Related]
28. Inhibition of tumor cell-platelet interactions and tumor metastasis by the calcium channel blocker, nimodipine.
Honn KV; Onoda JM; Diglio CA; Carufel MM; Taylor JD; Sloane BF
Clin Exp Metastasis; 1984; 2(1):61-72. PubMed ID: 6543691
[TBL] [Abstract][Full Text] [Related]
29. [Role of blood platelets and prostaglandins in blood-borne metastases].
Tanaka K; Fukumoto S
Gan To Kagaku Ryoho; 1983 Sep; 10(9):1944-7. PubMed ID: 6614932
[TBL] [Abstract][Full Text] [Related]
30. The role of platelet activation in tumor metastasis.
Borsig L
Expert Rev Anticancer Ther; 2008 Aug; 8(8):1247-55. PubMed ID: 18699763
[TBL] [Abstract][Full Text] [Related]
31. Role of adhesion molecules and platelets in TNF-induced adhesion of tumor cells to endothelial cells: implications for experimental metastasis.
Stoelcker B; Hafner M; Orosz P; Nieswandt B; Männel DN
J Inflamm; 1995-1996; 46(3):155-67. PubMed ID: 8844496
[TBL] [Abstract][Full Text] [Related]
32. [Disordered function of the vascular-thrombocyte link in the hemostatic system during tumor growth].
Liubina LV; Tlepshukov IK
Biull Eksp Biol Med; 1989 Dec; 108(12):716-8. PubMed ID: 2634448
[TBL] [Abstract][Full Text] [Related]
33. Plasma membrane vesicles as mediators of interactions between tumor cells and components of the hemostatic and immune systems.
Gasic GJ; Gasic TB
Prog Clin Biol Res; 1982; 89():429-44. PubMed ID: 7111308
[No Abstract] [Full Text] [Related]
34. Tumor cell-platelet-endothelial cell interactions and prostaglandin metabolism.
Honn KV; Menter DG; Onoda JM; Steinert BW; Diglio CA; Taylor JD; Sloane BF
Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():981-5. PubMed ID: 2960216
[TBL] [Abstract][Full Text] [Related]
35. Platelet-tumor cell interaction.
Seyfert UT; Hauck W; Berger H; Böhm D; Zankl H; Albert FW
Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(5):685-97. PubMed ID: 1709902
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of breast cancer metastasis by dual liposomes to disturb complex formation.
Wenzel J; Zeisig R; Fichtner I
Int J Pharm; 2009 Mar; 370(1-2):121-8. PubMed ID: 19100823
[TBL] [Abstract][Full Text] [Related]
37. Mechanistic explanation for platelet contribution to cancer metastasis.
Stegner D; Dütting S; Nieswandt B
Thromb Res; 2014 May; 133 Suppl 2():S149-57. PubMed ID: 24862136
[TBL] [Abstract][Full Text] [Related]
38. Effects of 5-(2-chlorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine hydrochloride (Ticlopidine), a platelet aggregation inhibitor, on blood-borne metastasis.
Kohga S; Kinjo M; Tanaka K; Ogawa H; Ishihara M; Tanaka N
Cancer Res; 1981 Nov; 41(11 Pt 1):4710-4. PubMed ID: 7306988
[TBL] [Abstract][Full Text] [Related]
39. Review of Growth Inhibitory Peptide as a biotherapeutic agent for tumor growth, adhesion, and metastasis.
Muehlemann M; Miller KD; Dauphinee M; Mizejewski GJ
Cancer Metastasis Rev; 2005 Sep; 24(3):441-67. PubMed ID: 16258731
[TBL] [Abstract][Full Text] [Related]
40. Signaling pathways for induction of platelet aggregation by SAS tongue cancer cells--a mechanism of hematogenous metastasis.
Chang MC; Chan CP; Ho YS; Lee JJ; Lin PS; Lin BR; Huang YL; Hahn LJ; Yeh HW; Wang YJ; Jeng JH
J Oral Pathol Med; 2009 May; 38(5):434-40. PubMed ID: 18811671
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
